# Pharmacokinetics and Pharmacodynamics Study of BCD-066 Compared to Aranesp® in Healthy Volunteers

> **NCT02506881** · PHASE1 · COMPLETED · sponsor: **Biocad** · enrollment: 74 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Darbepoetin alfa

## Key facts

- **NCT ID:** NCT02506881
- **Lead sponsor:** Biocad
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2016-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02506881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02506881, "Pharmacokinetics and Pharmacodynamics Study of BCD-066 Compared to Aranesp® in Healthy Volunteers". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02506881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*